HIV-1 latent reservoir: Size matters

Future Virology

Volumn 11, Issue 12, 2016, Pages 785-794

  Hodel, Flavia ^a   Patxot, Marion ^a   Snäkä, Tiia ^a   Ciuffi, Angela ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Assays; DNA; HIV 1; Latent reservoir; Quantification; RNA; Size

Indexed keywords

CELL ASSAY; DROPLET DIGITAL POLYMERASE CHAIN REACTION; GOLD STANDARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; INDUCIBLE CELL ASSOCIATED RNA EXPRESSION IN DILUTION ASSAY; LATENT RESERVOIR; MEASUREMENT ACCURACY; MURINE; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE VIRAL OUTGROWTH ASSAY; REVIEW; SINGLE MOLECULE ARRAY; TAT REV INDUCED LIMITING DILUTION ASSAY; VIRAL OUTGROWTH ASSAY; VIRAL PHENOMENA AND FUNCTIONS; VIRUS LATENCY;

EID: 85002857757     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl-2016-0093     Document Type: Review

References (32)

1. AIDS epidemic update: December 2007. UNAIDS, Geneva. http://data.unaids.org/pub/
2. Bruner KM, Hosmane NN, Siliciano RF. Towards an HIV-1 cure: measuring the latent reservoir. Trends Microbiol. 23(4), 192-203 (2 015).
3. Kumar A, Darcis G, Van Lint C, Herbein G. Epigenetic control of HIV-1 post integration latency: implications for therapy. Clin. Epigenetics 7, 103 (2015).
4. Melkova Z, Shankaran P, Madlenakova M, Bodor J. Current views on HIV-1 latency, persistence, and cure. Folia Microbiol. doi:10.1007/ s12223-016-0474-7 (2016) (Epub ahead of print).
5. Rothenberger MK, Keele BF, Wietgrefe SW et al. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proc. Natl Acad. Sci. USA 112(10), e1126-e1134 (2015).
6. Whitney JB, Hill AL, Sanisetty S et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 512(7512), 74-77 (2014).
7. Ciuff A, Mohammadi P, Golumbeanu M, di Iulio J, Telenti A. Bioinformatics and HIV latency. Curr. HIV/AIDS Rep. 12(1), 97-106 (2015).
8. Lorenzo-Redondo R, Fryer HR, Bedford T et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530(7588), 51-56 (2016).
9. Fletcher CV, Staskus K, Wietgrefe SW et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl Acad. Sci. USA 111(6), 2307-2312 (2014).
10. Chun T-W, Moir S, Fauci AS. HIV reservoirs as obstacles and opportunities for an HIV cure. Nat. Immunol. 16(6), 584-589 (2015).
11. Ho Y-C, Shan L, Hosmane NN et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell. 155(3), 540-551 (2013).
12. Sattentau QJ, Stevenson M. Macrophages and HIV-1: an unhealthy constellation. Cell Host Microbe. 19(3), 304-310 (2016).
13. Laird GM, Eisele EE, Rabi SA et al. Rapid quantifcation of the latent reservoir for HIV-1 using a viral outgrowth assay. PLoS Pathog. 9(5), e1003398 (2013).
14. Kimata JT, Rice AP, Wang J. Challenges and strategies for the eradication of the HIV reservoir. Curr. Opin. Immunol. 42, 65-70 (2016).
15. + T cells from patients on suppressive antiretroviral therapy. Proc. Natl Acad. Sci. USA 111(19), 7078-7083 (2014).
16. Metcalf Pate KA, Pohlmeyer CW, Walker-Sperling VE et al. A murine viral outgrowth assay to detect residual HIV type 1 in patients with undetectable viral loads. J. Infect. Dis. 212(9), 1387-1396 (2015).
17. Massanella M, Yek C, Lada SM, Strain MC, Richman DD. Improvedassays to measure the inducible latent HIV reservoir. Towards an HIV CureSymposium Abstract PE18. Vancouver, Canada (July 2015).
18. Kiselinova M, Pasternak AO, De Spiegelaere W, Vogelaers D, Berkhout B, Vandekerckhove L. Comparison of droplet digital PCR and seminested real-time PCR for quantifcation of cell-associated HIV-1 RNA. PLoS ONE 9(1), e85999 (2014).
19. Bosman KJ, Nijhuis M, van Ham PM et al Comparison of digital PCR platforms and semi-nested qPCR as a tool to determine the size of the HIV reservoir. Sci. Rep. 5, 13811 (2015).
20. Eriksson S, Graf EH, Dahl V et al Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 9(2), e1003174 (2013).
21. Avettand-Fènoël V, Hocqueloux L, Ghosn J et al. Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications. Clin. Microbiol. Rev. 29(4), 859-880 (2016).
22. Mexas AM, Graf EH, Pace MJ et al. Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials. AIDS 26(18), 2295-2306 (2012).
23. Strain MC, Lada SM, Luong T et al. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS ONE 8(4), e55943 (2013).
24. Droplet Digital PCR Applications Guide; Bio-Rad Laboratories, Inc. Bulletin offciel Bio-Rad 6407 Rev A. www.bio-rad.com/webroot/web/pdf/lsr
25. Procopio FA, Fromentin R, Kulpa DA et al. A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals. EBioMedicine 2(8), 874-883 (2015).
26. Wilson DH, Rissin DM, Kan CW et al. The Simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing. J. Lab. Autom. 21(4), 533-547 (2016).
27. Fischer SK, Joyce A, Spengler M et al. Emerging technologies to increase ligand binding assay sensitivity. AAPS J. 17(1), 93-101 (2015).
28. Yeung D, Ciotti S, Purushothama S et al. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/ml levels of cytokines in human serum. J. Immunol. Methods. 437, 53-63 (2016).
29. Wilson DH, Hanlon DW, Provuncher GK et al. Fifth-generation digital immunoassay for prostate-specifc antigen by single molecule array technology. Clin. Chem. 57(12), 1712-1721 (2011).
30. Bogoslovsky T, Wilson D, Chen Y et al. Increases of plasma levels of glial fbrillary acidic protein, tau, and amyloid β up to 90 days after traumatic brain injury. J. Neurotrauma 10.1089 /neu.2015.4333 (2016).
31. Kiselinova M, De Spiegelaere W, Buzon MJ, Malatinkova E, Lichterfeld M, Vandekerckhove L. Integrated and total HIV-1 DNA predict ex vivo viral outgrowth. PLoS Pathog. 12(3), e1005472 (2016).
32. Williams J P, Hurst J, Stöhr W et al. HI V-1 DNA predicts disease progression and post-treatment virological control. Elife 3, e03821 (2014).